| Announce Date | 12/09/2025 |
| EPS Normalized Actual | $0.44 (Miss by $-0.336) |
| EPS GAAP Actual | $0.44 (Miss by $-0.336) |
| Revenue Actual | $0.472508B |
| Revenue Surprise | Beat by $472.508M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Apr 2030 | 9.6 | 26.79 | 6.54117 | 10.58552 | 1 |
| Apr 2030 | 8.95 | 28.74 | 8.44961 | 9.34018 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | -0.61 | -0.61 | 0.472508B | 74.34% | 472.51M |
| FQ3 2025 (Aug 2025) | -1.44 | -1.44 | 0.313533B | -1.75% | 313.53M |
| FQ2 2025 (Apr 2025) | 0.59 | 0.59 | 0.242234B | 18.68% | 242.23M |
| FQ1 2025 (Jan 2025) | -0.0626 | -0.0626 | 0.139753B | -123.14% | 139.75M |
| FQ4 2024 (Oct 2024) | -0.76 | -0.76 | 0.121252B | -49.12% | 121.25M |
| FQ3 2024 (Jul 2024) | 0.76 | 0.76 | 0.319008B | 25.1% | 319.01M |
| FQ2 2024 (Apr 2024) | 0.22 | 0.22 | 0.196979B | 5.55% | 196.98M |
| FQ1 2024 (Jan 2024) | 0.0005 | 0.0005 | 0.311846B | 53.16% | 311.85M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (May 2028) | 1.97 | -- | 1.84779 | 2.10454 | 4 |
| FQ1 2028 (Feb 2028) | 1.58 | -- | 1.48199 | 1.68791 | 6 |
| FQ4 2027 (Nov 2027) | 1.37 | -- | 1.28501 | 1.46356 | 4 |
| FQ3 2027 (Aug 2027) | 1.205 | -- | 1.13025 | 1.28729 | 3 |
| FQ2 2027 (Apr 2027) | 1.34 | -- | 1.28689 | 1.39122 | 3 |
| FQ1 2027 (Jan 2027) | 1.26 | -- | 1.21006 | 1.30817 | 3 |
| FQ4 2026 (Nov 2026) | 1.0692 | 157.05 | 0.98333 | 1.17064 | 2 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (May 2028) | 0.79B | -- | 0.75B | 0.83B | 3 |
| FQ1 2028 (Feb 2028) | 0.7B | -- | 0.67B | 0.74B | 5 |
| FQ4 2027 (Nov 2027) | 0.65B | -- | 0.62B | 0.69B | 5 |
| FQ3 2027 (Aug 2027) | 0.57B | -- | 0.54B | 0.6B | 4 |
| FQ2 2027 (Apr 2027) | 0.27B | -- | 0.26B | 0.28B | 4 |
| FQ1 2027 (Jan 2027) | 0.25B | -- | 0.24B | 0.26B | 4 |
| FQ4 2026 (Nov 2026) | 0.55B | 13.47 | 0.51B | 0.59B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | -0.61 | -0.61 | 100% | |
| FQ3 2025 (Aug 2025) | -1.44 | -1.44 | 100% | |
| FQ2 2025 (Apr 2025) | 0.59 | 0.59 | 100% | |
| FQ1 2025 (Jan 2025) | -0.0626 | -0.0626 | 100% | |
| FQ4 2024 (Oct 2024) | -0.76 | -0.76 | 100% | |
| FQ3 2024 (Jul 2024) | 0.76 | 0.76 | 100% | |
| FQ2 2024 (Apr 2024) | 0.22 | 0.22 | 100% | |
| FQ1 2024 (Jan 2024) | 0.0005 | 0.0005 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0B | $0.47B | $472.51M | 100% |
| FQ3 2025 (Aug 2025) | $0B | $0.31B | $313.53M | 100% |
| FQ2 2025 (Apr 2025) | $0B | $0.24B | $242.23M | 100% |
| FQ1 2025 (Jan 2025) | $0B | $0.14B | $139.75M | 100% |
| FQ4 2024 (Oct 2024) | $0B | $0.12B | $121.25M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $0.32B | $319.01M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $0.2B | $196.98M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $0.31B | $311.85M | 100% |